Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-10-265299
Filing Date
2010-11-19
Accepted
2010-11-19 16:43:46
Documents
5
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K AMENDMENT NO. 1 d10ka.htm 10-K/A 403188
2 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 9227
3 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 9240
4 SECTION 906 CEO CERTIFICATION dex321.htm EX-32.1 3226
5 SECTION 906 CFO CERTIFICATION dex322.htm EX-32.2 3333
  Complete submission text file 0001193125-10-265299.txt   429779
Mailing Address 801 CORPORATE CENTER DRIVE SUITE 210 RALEIGH NC 27607
Business Address 801 CORPORATE CENTER DRIVE SUITE 210 RALEIGH NC 27607 919 582 9050
BIODELIVERY SCIENCES INTERNATIONAL INC (Filer) CIK: 0001103021 (see all company filings)

EIN.: 352089858 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-31361 | Film No.: 101206060
SIC: 2834 Pharmaceutical Preparations